Non-neutralizing antibodies: Deleterious or propitious during SARS-CoV-2 infection?
Isabella Zanella, Melania Degli Antoni, Valentina Marchese, Francesco Castelli, Eugenia Quirós-Roldán
Topics & Concepts
AntibodyDiseaseImmunologyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyVaccinationNeutralizing antibodyAntibody-dependent enhancementMedicineVirulenceInfectious disease (medical specialty)2019-20 coronavirus outbreakBiologyVirusOutbreakViral replicationGenePathologyBiochemistrySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research StudiesViral Infections and Immunology Research